P8Z Stock Analysis: Bumitama Agri | SG

Farm Products | SG, Singapore | Market Cap: 3.624m SGD | 12M Return: 93.3% | SG2E67980267 | Charts, Fundamentals & Technical Analysis

Crude Palm Oil, Palm Kernel, Edible Oils, Fertilizers
Total Rating 73
Safety 90
Buy Signal 1.12
Farm Products
Industry Rotation: +5.8
Market Cap: 2.86B
Avg Turnover: 4.22M
Risk 3d forecast
Volatility54.5%
VaR 5th Pctl8.26%
VaR vs Median-6.91%
Reward TTM
Sharpe Ratio1.52
Rel. Str. IBD94.7
Rel. Str. Peer Group95
Character TTM
Beta0.051
Beta Downside-0.230
Hurst Exponent0.474
Drawdowns 3y
Max DD30.72%
CAGR/Max DD2.24
CAGR/Mean DD10.59

Warnings

No concerns identified

Tailwinds

Rs Leader
Idiosyncratic Leader

Seasonality 11.7 years of data

Jan +0.0% 7
Feb -1.7% 15
Mar +1.6% 21
Apr +5.1% 37
May -2.7% 25
Jun -1.3% 42
Jul -0.5% 7
Aug +2.1% 40
Sep +0.5% 2
Oct +1.1% 17
Nov +2.7% 56
Dec -1.6% 40

How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.

Description: P8Z Bumitama Agri

Bumitama Agri Ltd. is an Indonesia-based investment holding company specializing in the production and distribution of crude palm oil (CPO) and palm kernel (PK). The firm manages a vertically integrated supply chain that includes oil palm plantations, processing mills, and fertilizer blending facilities. Its core operations encompass the entire lifecycle of palm products, from cultivation and harvesting to the industrial processing and trading of edible oils.

The company operates within the agricultural products sector, where profitability is heavily influenced by global commodity price fluctuations and land bank maturity profiles. As an upstream producer, Bumitama Agri relies on biological asset appreciation and efficient extraction rates to drive margins. Investors may find deeper insights into these historical performance metrics at ValueRay. The business model also includes management consultancy services and specialized trading activities related to the palm oil industry.

Headlines to Watch Out For
  • CPO price volatility dictates core revenue and operating margins
  • Fresh Fruit Bunch yields improve through maturing plantation age profile
  • Indonesian export levy and tax policy shifts impact net realizations
  • Fertilizer and labor costs drive plantation production cost per tonne
Piotroski VR-10 (Strict) 8.5
Net Income: 2803b TTM > 0 and > 6% of Revenue
FCF/TA: 0.14 > 0.02 and ΔFCF/TA 5.17 > 1.0
NWC/Revenue: 14.93% < 20% (prev 24.45%; Δ -9.52% < -1%)
CFO/TA 0.20 > 3% & CFO 4672b > Net Income 2803b
Net Debt/EBITDA: error (cannot be calculated)
Current Ratio: 1.89 > 1.5 & < 3
Outstanding Shares: last quarter (1.73b) vs 12m ago 0.0% < -2%
Gross Margin: 27.96% > 18% (prev 26.04%; Δ 1.92% > 0.5%)
Asset Turnover: 91.02% > 50% (prev 79.78%; Δ 11.25% > 0%)
Interest Coverage Ratio: 18.50 > 6 (EBIT TTM 3093b / Interest Expense TTM 167b)
Altman Z'' 6.62
A: 0.13 (Total Current Assets 6319b - Total Current Liabilities 3340b) / Total Assets 22865b
B: 0.60 (Retained Earnings 13659b / Total Assets 22865b)
C: 0.14 (EBIT TTM 3093b / Avg Total Assets 21919b)
D: 2.73 (Book Value of Equity 15019b / Total Liabilities 5501b)
Altman-Z'' = 6.62 = AAA
Beneish M -3.69
DSRI: 0.16 (Receivables 131b/691b, Revenue 19951b/16732b)
GMI: 0.93 (GM 26.04% / 27.96%)
AQI: 0.93 (AQ_t 0.46 / AQ_t-1 0.49)
SGI: 1.19 (Revenue 19951b / 16732b)
TATA: -0.08 (NI 2803b - CFO 4672b) / TA 22865b)
Beneish M = -3.69 (Cap -4..+1) = AAA
What is the price of P8Z shares?

As of September 05, 2026, the stock is trading at SGD 2.07 with a total of 1,633,700 shares traded. Over the past week, the price has changed by -0.96%, over one month by +21.29%, over three months by +31.91% and over the past year by +93.30%.

Current recommended Stop Loss: 1.90 (which is 8.2% or 1.9 ATR below the current price).

Is P8Z a buy, sell or hold?

Bumitama Agri has no consensus analysts rating.

Bumitama Agri (P8Z) - Fundamental Data Overview as of 02 September 2026
Market Cap USD = 2.86b (3.62b SGD * 0.7891 SGD.USD)
Market Cap IDR = 50591b (3.62b SGD * 13958.4668 SGD.IDR)
P/E Trailing = 15.2857
P/E Forward = 13.3333
P/S = 2.1914
P/B = 3.1447
P/EG = 1.0586
Revenue TTM = 19951b IDR
EBIT TTM = 3093b IDR
EBITDA TTM = 4083b IDR
Long Term Debt = 1791b IDR (from longTermDebt, last quarter)
Short Term Debt = 1657b IDR (from shortLongTermDebt, last quarter)
 Debt = unknown
 Net Debt = unknown
 Enterprise Value = 48087b IDR (50591b + (null Debt) - CCE 2503b)
Interest Coverage Ratio = 18.50 (Ebit TTM 3093b / Interest Expense TTM 167b)
EV/FCF = 15.38x (Enterprise Value 48087b / FCF TTM 3126b)
FCF Yield = 6.50% (FCF TTM 3126b / Enterprise Value 48087b)
FCF Margin = 15.67% (FCF TTM 3126b / Revenue TTM 19951b)
Net Margin = 14.05% (Net Income TTM 2803b / Revenue TTM 19951b)
Gross Margin = 27.96% ((Revenue TTM 19951b - Cost of Revenue TTM 14373b) / Revenue TTM)
Gross Margin QoQ = none% (prev none%)
Tobins Q-Ratio = 2.10 (Enterprise Value 48087b / Total Assets 22865b)
 Interest Expense / Debt = unknown (Interest Expense 167b / Debt none)
 Taxrate = 27.79% (1295b / 4660b)
NOPAT = 2233b (EBIT 3093b * (1 - 27.79%))
Current Ratio = 1.89 (Total Current Assets 6319b / Total Current Liabilities 3340b)
 Debt / Equity = unknown (Debt none)
 Debt / EBITDA = unknown (Net Debt none / EBITDA 4083b)
 Debt / FCF = unknown (Net Debt none / FCF TTM 3126b)
 Total Stockholder Equity = 14126b (last 4 quarters mean from totalStockholderEquity)
RoA = 12.79% (Net Income 2803b / Total Assets 22865b)
RoE = 19.84% (Net Income TTM 2803b / Total Stockholder Equity 14126b)
RoCE = 19.43% (EBIT 3093b / Capital Employed (Equity 14126b + L.T.Debt 1791b))
RoIC = 12.05% (NOPAT 2233b / Invested Capital 18527b)
WACC = 6.16% (E(50591b)/V(50591b) * Re(6.16%) + (debt-free company))
Discount Rate = 6.16% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -52.22 | Cagr: -0.09%
[DCF] Terminal Value 77.97% ; FCFF base≈2589b ; Y1≈2968b ; Y5≈4368b
[DCF] Fair Price = 37.9k (EV 65725b - Net Debt 0.0 = Equity 65725b / Shares 1.73b; r=8.35% [WACC [floored]]; 5y FCF grow 15.0% → 2.50% )
Revenue Correlation: 97.75 | Revenue CAGR: 13.66% | SUE: N/A | # QB: 0
EPS current Year (2026-12-31): EPS=2176.32 | Chg30d=+5.32% | Revisions=-25% | GrowthEPS=+34.7% | GrowthRev=+21.1%
EPS next Year (2027-12-31): EPS=2214.70 | Chg30d=+4.34% | Revisions=-25% | GrowthEPS=+1.8% | GrowthRev=+2.5%
[Analyst] Revisions Ratio: -40% (up=0, down=2)